Evidence map›Paper›PMID 33795764›Full record

ArticleScientific reports2021

Interim and end-treatment

Ana María García Vicente, Mariano Amo-Salas, Javier Cassinello Espinosa, Roberto Gómez Díaz, Ángel Soriano Castrejón

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Evaluating response to radium-223 usingAnnals of nuclear medicine · 2025
    Article
  2. Article
  3. Review
  4. Review
  5. Beyond the Prognostic Value of 2-[Diagnostics (Basel, Switzerland) · 2022
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ana María García VicenteNuclear Medicine Department, Hospital General Universitario, C/Obispo Rafael Torija S/N, 13005, Ciudad Real, Spain. angarvice@yahoo.es.
Mariano Amo-SalasMathematics Department, Universidad de Castilla-La Mancha, Ciudad Real, Spain.
Javier Cassinello EspinosaOncology Department, Hospital Universitario de Guadalajara, Guadalajara, Spain.
Roberto Gómez DíazOncology Department, Hospital General Universitario, Ciudad Real, Spain.
Ángel Soriano CastrejónNuclear Medicine Department, Hospital General Universitario, C/Obispo Rafael Torija S/N, 13005, Ciudad Real, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To assess the predictive and prognostic aim of interim and end-treatment

Indexed as

AgedBone and BonesBone NeoplasmsCholineDisease-Free SurvivalDisease ProgressionHumansMaleMiddle AgedMolecular MedicineMultivariate AnalysisPositron Emission Tomography Computed TomographyProportional Hazards ModelsProspective StudiesProstatic NeoplasmsRadioisotopesCholinefluorocholineRadioisotopesRadiumradium Ra 223 dichloride

Identifiers

PMID33795764
PMCPMC8016973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.